These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Zhan KY; Eskander A; Kang SY; Old MO; Ozer E; Agrawal AA; Carrau RL; Rocco JW; Teknos TN Oral Oncol; 2017 Oct; 73():152-159. PubMed ID: 28939068 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338 [TBL] [Abstract][Full Text] [Related]
5. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer. Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage. Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733 [TBL] [Abstract][Full Text] [Related]
7. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition. Miccio JA; Verma V; Kelly J; Kann BH; An Y; Park HS; Eskander A; Burtness B; Husain Z Oral Oncol; 2019 Dec; 99():104447. PubMed ID: 31630059 [TBL] [Abstract][Full Text] [Related]
8. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer. Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status. Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919 [TBL] [Abstract][Full Text] [Related]
10. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort. Geltzeiler M; Bertolet M; Albergotti W; Gleysteen J; Olson B; Persky M; Gross N; Li R; Andersen P; Kim S; Ferris RL; Duvvuri U; Clayburgh D Oral Oncol; 2018 Sep; 84():82-87. PubMed ID: 30115481 [TBL] [Abstract][Full Text] [Related]
11. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study. Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331 [TBL] [Abstract][Full Text] [Related]
13. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma. Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021 [TBL] [Abstract][Full Text] [Related]
14. Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients. Ryan WR; Xu MJ; Ochoa E; Plonowska-Hirschfeld KA; Zebolsky AL; Ha PK; Bewley AF; Mallen-St Clair J; Joshi AS; Coffey CS; Faraji F; MacDonald BV; Houlton JJ; Gobillot TA; Curry JM; Philips R; Hackman TG; Richmon JD; Holcomb AJ; Coughlin AM; Panwar A; Smith RB; Herberg ME; Fakhry C; Cognetti DM Cancer; 2021 Sep; 127(17):3092-3106. PubMed ID: 33957701 [TBL] [Abstract][Full Text] [Related]
15. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Kompelli AR; Morgan P; Li H; Harris W; Day TA; Neskey DM Otolaryngol Head Neck Surg; 2019 May; 160(5):855-861. PubMed ID: 30526292 [TBL] [Abstract][Full Text] [Related]
17. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442 [TBL] [Abstract][Full Text] [Related]
18. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment. Cramer JD; Ferris RL; Kim S; Duvvuri U Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235 [TBL] [Abstract][Full Text] [Related]
19. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan. Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391 [TBL] [Abstract][Full Text] [Related]
20. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era. Gal TJ; O'Brien KJ; Chen Q; Huang B Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]